The U.S. Food and Drug Administration (FDA) has issued three final guidances and one draft guidance providing greater regulatory clarity for industry on the use of nanotechnology in FDA-regulated products.
from IFT Daily News http://ift.tt/1oilN1z
from IFT Daily News http://ift.tt/1oilN1z
No comments:
Post a Comment